Effects of adjuvants on IgG subclasses elicited by virus-like particles.
about
A Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV ImmunogenBiocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccinesNegatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine.Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.Characterization of novel Omp31 antigenic epitopes of Brucella melitensis by monoclonal antibodiesAntiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responsesIncorporation of membrane-anchored flagellin or Escherichia coli heat-labile enterotoxin B subunit enhances the immunogenicity of rabies virus-like particles in mice and dogs.Effect of premedications in a murine model of asparaginase hypersensitivityChimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection modelA Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV.Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as AdjuvantA Nanoparticle Based Sp17 Peptide Vaccine Exposes New Immuno-Dominant and Species Cross-reactive B Cell Epitopes.Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection.The effects of HIV Tat DNA on regulating the immune response of HIV DNA vaccine in mice.Mucosal adjuvants for influenza virus-like particle vaccine.Self-assembly of hexahistidine-tagged tobacco etch virus capsid protein into microfilaments that induce IgG2-specific response against a soluble porcine reproductive and respiratory syndrome virus chimeric proteinBacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action.Systems vaccinology for cancer vaccine development.Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems.A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant response.Efficient production of recombinant glycoprotein D of herpes simplex virus type 2 in Pichia pastoris and its protective efficacy against viral challenge in mice.Immunomodulation of Lactobacillus reuteri CRL1324 on Group B Streptococcus Vaginal Colonization in a Murine Experimental Model.Humoral and cellular immune responses to Yersinia pestis Pla antigen in humans immunized with live plague vaccine.
P2860
Q27302081-BFE8B932-6491-4FEB-A82D-C39BEA5E5D3EQ27333734-EFF614E9-54F6-4184-A2D9-A4357D3DA0ECQ30361416-54B9C8A6-40D8-4BDD-A0C5-FE4AB7C2290EQ30399700-BC0FD5D1-1E34-4E8B-A1EF-DDEA34FA3B95Q33691610-30079A2C-7A11-4C0D-AEA2-39531C47947DQ33867299-C6C90032-FABC-4536-AE71-9BA76FE7BD95Q34455275-D6BDF151-652D-4B31-9895-1DC5B725CD58Q35140889-D2906E2B-D00A-476E-B856-DC63F91DB4A7Q35156439-05FC59F3-DFCF-4CA1-A87F-82D579B361D9Q35232804-E8093543-C3AB-4EB2-9520-4FBA8F67B67AQ35319744-AA039A01-A09C-4FC3-921C-68DFAD1E7209Q35757125-6A6A5B45-5079-4949-9670-2AFCFEEB1D60Q36086281-1DC1FD82-ACEB-4EB1-AC2C-BEEAC2574BC6Q36409524-60AF2D2F-1CA0-40E2-8007-E57C78E6B96BQ36846035-F20A42E0-2AF2-4BA8-9548-0B43900367A3Q37364423-844D6747-247B-44A7-B804-FA942DA14848Q37404044-EA13F1F4-E620-4FA2-93F5-9C15D796E31EQ37449926-03F3E388-FCDD-41E9-ADD1-45B619BD93EBQ37521363-30CDCD30-978A-4CA0-BCF5-585084F580F5Q38207141-4E2B0743-52E7-4ADC-A5A1-86772CC59D48Q38618258-6DFC09E4-571D-4803-98B9-7612FA5DCC1EQ40121621-745C0EF4-2E40-4B36-B2B8-E816F0554B21Q40443062-7A94E29C-BF14-4849-B227-5BE384E941D4Q40918656-447B0C05-56D2-4BEF-8B8D-F32E73853FFCQ55456478-BA4A5A15-13D6-4818-B368-E034FA13AA8E
P2860
Effects of adjuvants on IgG subclasses elicited by virus-like particles.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effects of adjuvants on IgG subclasses elicited by virus-like particles.
@ast
Effects of adjuvants on IgG subclasses elicited by virus-like particles.
@en
type
label
Effects of adjuvants on IgG subclasses elicited by virus-like particles.
@ast
Effects of adjuvants on IgG subclasses elicited by virus-like particles.
@en
prefLabel
Effects of adjuvants on IgG subclasses elicited by virus-like particles.
@ast
Effects of adjuvants on IgG subclasses elicited by virus-like particles.
@en
P2860
P50
P356
P1476
Effects of adjuvants on IgG subclasses elicited by virus-like particles.
@en
P2093
Franco M Buonaguro
Maria Luisa Visciano
P2860
P2888
P356
10.1186/1479-5876-10-4
P577
2012-01-05T00:00:00Z
P5875
P6179
1024971385